| 15:12 | First To File : Issue 9 |  |
| 15:05 | MassBio - Pfizer Pharma Day to ignite breakthrough partnerships | |
| 14:52 | Cronache di Borsa - Mercoledì 1 Febbraio |  |
| 11:09 | GSK: bénéfice 2022 dopé par la scission des soins grand public |  |
| 08:44 | Morning Briefing - Markt Schweiz |  |
| 08:27 | Novartis présente la candidature d'un ancien de Pfizer pour son conseil | |
| 07:24 | Novartis schlägt früheren Pfizer-Manager für den Verwaltungsrat vor | |
| 07:13 | Wall Street : clôture en nette hausse dans l'attente du FOMC | |
| 05:59 | China mRNA vaccine development jumps into high gear | |
| 03:54 | Simcere Starts Marketing Oral COVID-19 Drug at 40% Less Than Price of Pfizer’s Pa.. | |
| 31/01 | Factbox-What ending the U.S. COVID health emergency means for your pocket | |
| 31/01 | Health Care Edges Higher After Mixed Pfizer Earnings -- Health Care Roundup | |
| 31/01 | Aktien New York Schluss: Dow und S&P 500 machen Vortagsverluste .. | |
| 31/01 | Ganancias destacadas en un Wall Street que descuenta resultados |  |
| 31/01 | MÄRKTE USA/Fester - US-Notenbank und Berichtssaison im Fokus | |
| 31/01 | Aktien New York: Deutliche Erholung vor Fed-Zinsentscheid und nach Zahle.. | |
| 31/01 | Bourses: l'Europe prudente, Wall Street positive | |
| 31/01 | Point marchés-L'Europe finit dans le désordre, attentisme sur les banques centrales | |
| 31/01 | Drugmaker Pfizer starts low with 2023 earnings forecast | |
| 31/01 | MÄRKTE USA/Etwas fester - US-Notenbank und Berichtssaison im Fokus | |
| 31/01 | Global markets live: GM, Pfizer, Exxon, UBS, Boeing... | |
| 31/01 | Wall Street : amorce de rebond à la veille de la Fed | |
| 31/01 | CAC40 : finit 1 mois de janvier record sans perdre de terrain | |
| 31/01 | Pfizer prevede forte calo vendite prodotti Covid in 2023 | |
| 31/01 | La prudence se confirme sur les marchés boursiers avant les banques centrales | |
| 31/01 | CAC40 : gain de +9,4% en janvier, beaucoup de stats en Europe | |
| 31/01 | Wall Street ouvre en hausse, la hausse des salaires ralentit | |
| 31/01 | Rückenwind durch Corona-Pandemie lässt bei Pfizer nach | |
| 31/01 | MÄRKTE USA/Wall Street zum Start leicht im Plus | |
| 31/01 | Pfizer prevede forte calo vendite prodotti Covid in 2023 | |
| 31/01 | Pfizer rechnet 2023 mit schleppendem Corona-Geschäft und weniger Gewinn | |
| 31/01 | Dpa-AFX-Überblick: UNTERNEHMEN vom 31.01.2023 - 15.15 Uhr | |
| 31/01 | Wall Street : les résultats peinent toujours à convaincre | |
| 31/01 | Les valeurs à suivre aujourd'hui à Wall Street - Mardi 31 janvier 2023 | |
| 31/01 | Investor optimism is about to be tested | |
| 31/01 | Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday | |
| 31/01 | Sector Update: Health Care | |
| 31/01 | Traders Tread Cautiously as Fed Starts Two-Day Meeting, Fueling Narrow Premarket Losses.. | |
| 31/01 | Aktien New York Ausblick: Leicht erholt vor Fed-Zinsentscheid | |
| 31/01 | Pfizer : annonce des revenus record mais anticipe des bénéfices 2023 en nette bai.. | |
| 31/01 | Pfizer Issues Downbeat Full-Year Outlook With Revenue From COVID-19 Products Set to Tum.. | |
| 31/01 | Pfizer: prevede ricavi da vaccini in calo a 13,5 miliardi nel 2023 | |
| 31/01 | Pfizer anticipe en 2023 un recul plus important des ventes de ses produits contre le CO.. | |
| 31/01 | Pfizer s'attend à une chute des ventes de son vaccin anti-Covid en 2023 | |
| 31/01 | Tranche Update on Pfizer Inc.'s Equity Buyback Plan announced on December 14, 2018. | |
| 31/01 | Pfizer Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 | |
| 31/01 | Pfizer Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | |
| 31/01 | Haleon appoints Pfizer Chief Financial Officer David Denton to board | |
| 31/01 | Les Bourses troublées par des indicateurs macroéconomiques | |
| 31/01 | Pfizer prevé ventas débiles de productos contra el COVID en 2023 | |
| 31/01 | Futures drop as earnings roll in, Fed rate decision in focus | |
| 31/01 | Pfizer: nel 2022 record, oltre 100 miliardi di dollari | |
| 31/01 | Pfizer : hausse de 44% du bénéfice net au 4e trimestre | |
| 31/01 | WDH: Pfizer rechnet 2023 mit schleppendem Corona-Geschäft und weniger Gewinn | |
| 31/01 | Pfizer's Q4 Adjusted Earnings, Revenue Rise; Fiscal 2023 Outlook Set | |
| 31/01 | Pfizer : Q4 Earnings Snapshot | |
| 31/01 | GUIDANCE: (PFE) PFIZER Forecasts Fiscal Year 2023 Adjusted EPS Range $3.25 - $3.. | |
| 31/01 | Earnings Flash (PFE) PFIZER Posts Q4 Revenue $24.29B, vs. Street Est of $24.40B | |
| 31/01 | Earnings Flash (PFE) PFIZER Posts Q4 Adjusted EPS $1.14, vs. Street Est of $1.04 | |
| 31/01 | Futures Continue to Trend Down Pre-Bell Ahead of Fed Policy Meeting; Asia, Europe Fall | |
| 31/01 | With Multiple Shots On Revenue-Generating Goals, Avalon GloboCare Positions For A Break.. | |
| 31/01 | Pfizer : Fourth Quarter 2022 Press Release | |
| 31/01 | Pfizer forecasts 2023 sales of COVID products below estimates | |
| 31/01 | Pfizer reports record full-year 2022 results and provides full-year 2023 financial guid.. | |
| 31/01 | Pfizer Inc. Provides Earnings Guidance for the Financial Year 2023 | |
| 31/01 | North American Morning Briefing: Stocks Seen Down -3- | |
| 31/01 | North American Morning Briefing: Stocks Seen Down as Rat.. | |
| 31/01 | European Midday Briefing: Mood Dampens Ahead of Central Banks | |
| 31/01 | USA-Les valeurs à suivre à Wall Street (actualisé) | |
| 31/01 | Tech Earnings, Fed Views Damp Wall Street Pre-Bell; Europe Down, Asia Off | |
| 31/01 | MARKT USA/Wall Street dürfte mit leichten Abschlägen starten | |
| 31/01 | Marketmind: 'Soft landing' or 'no landing'? | |
| 31/01 | CAC40 : la prudence domine avant de nombreux résultats | |
| 31/01 | Bolsa de Madrid: Un poco de tensión ante la Fed | |
| 31/01 | Un peu de tension avant la Fed | |
| 31/01 | En Direct des Marchés : Sanofi, Technip Energies, Elis, Seb, EuroA.. | |
| 31/01 | CAC 40 : la pause se prolonge malgré de bonnes surprises | |
| 31/01 | Dax vor Fed-Entscheid zur Eröffnung niedriger erwartet | |
| 31/01 | Marketmind: Mind the gap | |
| 31/01 | TAGESVORSCHAU/Dienstag, 31. Januar | |
| 31/01 | WOCHENVORSCHAU: Termine bis 13. Februar 2023 | |
| 31/01 | PrescriberPoint, Inc. announced that it has received funding from Eli Lilly and Company.. | |
| 30/01 | Wall Street termine en berne au début d'une semaine chargée, donc risquée | |
| 30/01 | Marketmind: Fasten your seatbelts | |
| 30/01 | Recogida de beneficios en Wall Street en una semana decisiva para el mercado | |
| 30/01 | Wall Street démarre en baisse une semaine économique très chargée | |
| 30/01 | South Africa Expects Delivery of Pediatric Pfizer/BioNTech COVID Vaccine Soon | |
| 30/01 | TAGESVORSCHAU/Dienstag, 31. Januar (vorläufige Fassung) | |
| 30/01 | Wdh/Aktien New York Ausblick: Schwach - Warten auf Tech-Zah.. | |
| 30/01 | Ribon Therapeutics and Pfizer Have Enter into an Agreement | |
| 30/01 | Moderna Gets FDA Breakthrough Designation for RSV Vaccine Candidate | |
| 30/01 | Paxlovid sales forecasts may change with Pfizer view on China | |
| 30/01 | South Africa Signs Collaboration With Pharmaceutical Association Including GSK, AstraZe.. | |
| 30/01 | Ribon Therapeutics, Inc. announced that it has received $25 million in funding from Pfi.. | |
| 29/01 | 'WamS': Bislang über 250 Corona-Impfschaden-Anträge genehmigt | |
| 27/01 | Health Care Down Ahead of Earnings -- Health Care Roundup | |
| 27/01 | S&P 500 Posts 2.5% Weekly Gain Led by Consumer Discretionary, Technology as Q4 GDP, Som.. | |
| 27/01 | WOCHENVORSCHAU: Termine bis 10. Februar 2023 | |
| 27/01 | Pfizer, BioNTech Reportedly in Talks with EU Over Reducing COVID-19 Vaccine Orders | |
| 27/01 | Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases - CDC | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
